National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$85.50
add to cart

Rights & Permissions

topleft topright

The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary (2010)
Board on Global Health (BGH)

Citation Manager

. "Appendix D Glossary." The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary. Washington, DC: The National Academies Press, 2010.

Please select a format:

BibTeX EndNote RefMan


Page
395
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


The Domestic and International Impacts of the 2009-H1N1 Influenza a Pandemic: Global Challenges, Global Solutions - Workshop Summary

RT-PCR, however, the RNA strand is first reverse transcribed into its DNA complement (complementary DNA, or cDNA) using the enzyme reverse transcriptase, and the resulting cDNA is amplified using traditional or real-time PCR. Reverse transcription PCR is not to be confused with real-time polymerase chain reaction (Q-PCR/qRT-PCR), which is also sometimes (incorrectly) abbreviated as RT-PCR (http://en.wikipedia.org/wiki/Reverse_transcription_polymerase_chain_reaction, accessed November 6, 2009).

RNA virus: A virus that contains ribonucleic acid (RNA) as its genetic material.

Salvage therapy: A final treatment for people who are nonresponsive to or cannot tolerate other available therapies for a particular condition and whose prognosis is often poor (http://www.medterms.com/script/main/art.asp?articlekey=9380, accessed December 17, 2009).

Serological: The use of immune serum in any of a number of tests (agglutination, precipitation, enzyme-linked immunosorbent assay, etc.) to measure the response (antibody titer) to infectious disease; the use of serological reactions to detect antigen.

Strain: A subgrouping of organisms within a species, characterized by some particular quality.

Surveillance: The continuing scrutiny of all aspects of occurrence and spread of a disease that is pertinent to effective control.

Vaccine: A biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body’s immune system to recognize the agent as foreign, destroy it, and “remember” it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Virulence: The degree of pathogenicity of an organism as evidenced by the severity of resulting disease and the organism’s ability to invade the host tissues.

Virulence factors: The properties (i.e., gene products) that enable a microorganism to establish itself on or within a host of a particular species and enhance its potential to cause disease.

Virus: A small infectious agent that can only replicate inside the cells of another organism. Viruses are too small to be seen directly with a light microscope.

Page
395
Front Matter (R1-R22)
Workshop Overview (1-94)
Appendix A1 Technical Report for State and Local Public Health Officials and School Administrators on CDC Guidance for School (K-12) Responses to Influenza during the 2009-2010 School Year (95-110)
A2 Predicting Emerging Diseases in the Twenty-first Century: The Case of Zoonotic Influenza (111-119)
A3 The Spring 2009 Influenza A H1N1 Outbreak: A Local Public Health Perspective (120-136)
A4 I nternational Law and Equitable Access to Vaccines and Antivirals in the Context of 2009-H1N1 Influenza (137-154)
A5 In Vitro and In Vivo Characterization of New Swine-Origin H1N1 Influenza Viruses (155-190)
A6 Estimation of the Reproductive Number and the Serial Interval in Early Phase of the 2009 Influenza A⁄H1N1 Pandemic in the USA (191-207)
A7 The Severity of Pandemic H1N1 Influenza in the United States, from April to July 2009: A Bayesian Analysis (208-247)
A8 Hard Choices in Difficult Situations: Ethical Issues in Public Health Emergencies (248-268)
A9 Rumors of Pandemic: Monitoring Emerging Disease Outbreaks on the Internet (269-282)
A10 Preliminary Observation of the Epidemiology of Seasonal and Pandemic Influenza A (H1N1) in South Africa, 2009 (283-296)
A11 Reflections on the 1976 Swine Flu Vaccination Program (297-305)
A12 Southern Hemisphere, Northern Hemisphere: A Global Influenza World (306-326)
A13 Influenza (H1N1) Pandemic 2009 (327-341)
A14 Origins and Evolutionary Genomics of the 2009 Swine-Origin H1N1 Influenza A Epidemic (342-380)
Appendix B Agenda (381-385)
Appendix C Acronyms (386-388)
Appendix D Glossary (389-396)
Appendix E Forum Member Biographies (397-418)